Business News, Personal Finance and Money News. Regulatory Recon GSK Eyes Pfizer, Merck Consumer Units Sanofi Sues Mylan Over Insulin Pen 2. October 2. 01. 7Posted 2. October 2. 01. 7. By Michael Mezher. Dc Mylan Dc Mylan Careers' title='Dc Mylan Dc Mylan Careers' />Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus USSanofi files patent infringement suit against Mylan over insulin pen Mass. Competition and antitrust at White Case is one of a top practice, with clients all over the world regularly seeking our expert advice and legal experience. Through the architecture, planning and design of mixeduse environments, Cooper Carry is committed to creating spaces that integrate a variety of functions into. Heather Bresch, Mylan N. V. Annual Salary 18. After Mylan purchased EpiPen from Merck KGaA in 2007, the company raised the price of a twopack by 500 percent. Meridian Medical Technologies, makers of Mylans EpiPen injector, issued a nationwide, voluntary recall of EpiPen and EpiPen Jr. According to the company. Professional Affiliations, Honors Recognition. Third President of the KoreanAmerican Intellectual Property Lawyers Association KAIPLA Washington DC Super. Newsletter with articles on current research finds, industry news, job listings and event schedules. Includes sign up form and information about the company. Learn more about Washington, DC area festivals and special events in July including annual events in Maryland and Virginia. Dc Mylan Dc Mylan Careers' title='Dc Mylan Dc Mylan Careers' />Device PharmafileIncyte grabs a new PD 1 checkpoint drug in 9. Honda Accord Camber Kit Install. M deal with Macro. Genics EndpointsAstra. Zeneca all in on severe asthma launch for late to the party benralizumab FierceTrump readies opioid plan, but some worry it wont be enough APPTC Therapeutics Stock Halted Street InsiderA Bipartisan Drug Cartel WSJOp Ed The opioid crackdown is making life untenable for chronic pain patients like me LA TimesTracking the Cost of Gene Therapy MIT Technology ReviewThe Medicines Co. Endpoint Gilead says drug profits must stay high to pay for innovation, but 1. LA TimesCalifornia just passed a law to rein in drug prices. Heres why its unlikely to make much difference STATFrom the C Suite Biopharma execs open up on what tests them as leaders STATBaxter expects 7. Hurricane Maria Reuters PressLawyers Scare Patients Out Of Taking Medication, Legal Reform Group Says ForbesBiogen Shares Hit After Poor US Sales for Muscular Atrophy Treatment The Street FierceHow much In a bold move, Celgene raises prices STAT Fierce5. Exemption Whats Actually Exempt, Part II FDA Law BlogIn Focus International. GSK draws up shopping list for Pfizer and Merck consumer unit Financial Times ReutersNew HIV treatments boost GSK sales after expensive start Financial TimesBill Gates Polio will be eradicated this year, the endgame is near CNBCBrexit Hits Life Science Investment Decisions As UK Risks Exclusion From Key EU Projects Pink Sheet Vantage Point European approvals face delay from agency move EP VantageWhats driving the rapid growth of the top 2. EndpointsPlague kills 1. Madagascar, cities most affected report ReutersChina approves Ebola vaccine co developed by Cansino Biologics and the military Bio. World FierceChugai applies for additional indication for breast cancer drug in Japan Pharma. Letter China Sets Norms For Foreign Trial Data Submissions Pink Sheet Consultation Deadline Approaches For New Industry Fees In Ireland Pink Sheet MSF appeals to Korea, Japan to withdraw proposals hindering access to generic drugs vaccines from RCEP negotiations Pharma. BizPharmaceuticals Biotechnology. To IPO or Not To IPO Life. Sci. VCPanel No Age Limit to Opioid Abuse MedpageCan changes to prescription labels and other public standards help tame the opioid crisisUSPAbbvies Jak flashes a warning for the whole class EP VantageAblynx IPO raises 2. M for its nanobody platform effort EndpointsWhy Precision Research May Lead To Blockbuster, Not Customized, Medicines ForbesAs Drugs Fail, Some Researchers Urge a Return to Alzheimers Roots XconomyAllergan preps 3. DTC to make Esmya a flagship womens health drug FierceRANDs Best Guess On Biosimilars Is 5. Bil. In Cost Savings Pink Sheet Evoke Pharmas Gimoti On Way To US FDA On Mixed Data SCRIP Novartis gives Arzerra a new lease of life EP VantageCRISPR, the Future of Life Science Research But Still Much to Learn MIT Technology ReviewType 3 diabetes more common than Type 1 and often misdiagnosed PharmafileQuad wins patent for alternative to magnetic beads in CAR T separation Bio. Pharma. ReporterGen. Sight Biologics CMO steps down as Barrett Katz takes over FierceBio. Invent CEO resigns in shift toward scientific leadership FierceScience Exchange signs University of California life science startup hub FierceY m. Abs raises 5. 0M funding to propel cancer duo into late stage testing FierceCatalent reorganizes after closing Pharmica purchase Drug DeliveryTakeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient Provider Engagement in Major Depressive Disorder Treatment using Digital Technology PressPharmaceutical and Biotechnology Study Results, Filings and Designations. Prometic Receives Fast Track Designation for PBI 4. Development for Idiopathic Pulmonary Fibrosis IPF PressKala Pharmaceuticals Submits New Drug Application to U. S. Food and Drug Administration for INVELTYSTM KPI 1. PressJanssens New Darunavir Based Single Tablet Regimen SYMTUZA Shows Positive Outcome in Treatment of Antiretroviral Nave HIV Patients PressSobi Alprolix Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B PressMedical Devices. Medical Device Development Tools Helping to Speed Medical Device Evaluation and Approval FDA VoiceRobotic assisted surgery more expensive, but not always more effective ReutersWill Experience Triumph Over New Robotics Innovation MDDIWhy Healthcare Entrepreneurs Developing Devices Or Software Better Grok Sales Marketing ForbesCan Machine Learning Save MedicineMDDINeural Analytics wins 1. Do. D for point of care TBI diag device Mass. DeviceEdwards Lifesciences slides on Q3 sales, earnings misses Mass. DeviceNu. Vasive posts Q3 earnings that beat EPS but miss on sales, 1. Mass. DeviceJ Js Life. Scan touts studies of One. Touch blood glucose monitoring system Drug DeliveryWhats Needed to Scale Digital Health Initiatives MDDIMedtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People with Type 2 Diabetes PressIncome, sales rise for 3. M Health Cares during Q3 Mass. DeviceUS Assorted Government. Mr. Quixote goes to Washington A bill would allow Medicare to negotiate drug prices STATPick the wrong Medicare drug plan and the cost will shock you CNBCAllergan invokes the victim defense to protect a brand name drug from a generic challenge STATPTAB Life Sciences Report Patent DocsAmgen, Hospira Challenge 7. M Biosimilar Judgment Law. Stacking The Deck Against Opioid Plaintiffs Law. Ensnarement 1. 01 Anatomy Of An Uncommon Patent Defense Law. US health insurer Anthems quarterly profit beats estimates ReutersCentene warns on Obamacare subsidy cuts, shares dive ReutersWalgreens Rebrand Of Rite Aids Will Take Three Years, Cost 7. M ForbesJohnson Johnson lawyers deny tampering allegations in hip case Mass. DeviceM. D. PA Declines to Dismiss MonitoringDeclaratory Judgment Action vs. Blood Temperature Regulation Device Drug Device LawUpcoming Meetings Events. Europe. Final Assessment Report, External CommentsAnswers and Project Plan for pharma JA on Regorafenib Stivarga EUnet. HTAMHRA pulls Evertogens GMP certificate after inspection In. Pharma. TechnologistAsia. Myriad Genetics Submits BRACAnalysis CDx for Approval in Japan Genome. WebIndia. Gujarat FDCA officials get trained for compliance through collaborations with MNCs Pharma. BizAustralia. Submissions received Alignment with European medical device regulatory framework TGAGeneral Health Other Interesting Articles.